These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 15570920)

  • 1. [Combination chemotherapy of TS-1 +cisplatin for inoperable gastric cancer].
    Koizumi W; Tanabe S; Higuchi K; Sasaki T; Nakayama N; Nagaba S; Azuma M; Shimoda T; Nishimura K; Nakatani K; Saigenji K
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):1957-61. PubMed ID: 15570920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combination therapy of a novel oral fluorouracil derivative TS-1 with low-dose cisplatin for recurrent and very advanced gastric cancer].
    Nakata B; Hirakawa K
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):1962-8. PubMed ID: 15570921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A phase I study of TS-1 and weekly cisplatin in patients with advanced gastric cancer].
    Kondo K; Kinoshita M; Kataoka M; Shimoyama S; Yamamura K; Ohshima Y; Furuta K; Chin K; Hatsuno T; Kajikawa M; Miura K; Horisawa M
    Gan To Kagaku Ryoho; 2005 May; 32(5):637-9. PubMed ID: 15918563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A pilot study of TS-1 combined with cisplatin in patients with advanced gastric cancer].
    Iwase H; Shimada M; Nakamura M; Iyo T; Nakarai K; Kaida S; Indo T; Okeya M; Mizuno T; Ina K; Kusugami K
    Gan To Kagaku Ryoho; 2002 Sep; 29(9):1575-82. PubMed ID: 12355943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical development of S-1 (TS-1) for advanced gastric cancer].
    Wasaburo K; Tanabe S; Higuchi K; Sasaki T; Nakayama N; Mihara S; Nakatani K; Nishimura K; Shimoda T; Azuma M; Katada C; Hanaoka N; Naruke A; Ryu T; Ishido K; Saigenji K
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():57-63. PubMed ID: 16897973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I/II study of S-1 plus cisplatin in patients with advanced gastric cancer: 2-week S-1 administration regimen.
    Sato Y; Kondo H; Honda K; Takahari D; Sumiyoshi T; Tsuji Y; Yoshizaki N; Niitsu Y
    Int J Clin Oncol; 2005 Feb; 10(1):40-4. PubMed ID: 15729600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I/II study of 3-week combination of S-1 and cisplatin chemotherapy for metastatic or recurrent gastric cancer.
    Lee JL; Kang HJ; Kang YK; Ryu MH; Chang HM; Kim TW; Sohn HJ; Kim H; Lee JS
    Cancer Chemother Pharmacol; 2008 Apr; 61(5):837-45. PubMed ID: 17579864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A phase I study of postoperative combination therapy with TS-1 and low dose cisplatin against stage IV gastric carcinoma].
    Sato Y; Kondo M; Takahashi M; Une Y; Homma S; Shoumura H; Maeda Y; Oshima T; Kohashi S; Nakano S; Todo S
    Gan To Kagaku Ryoho; 2007 Apr; 34(4):563-7. PubMed ID: 17431342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [TS-1/CDDP/Lentinan combination chemotherapy for inoperable advanced gastric cancer].
    Nagahashi S; Suzuki H; Nishiwaki M; Okuda K; Kurosawa Y; Terada S; Sugihara T; Andou K; Hibi T
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):1999-2003. PubMed ID: 15570928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of TS-1 combined with cisplatin for neoadjuvant chemotherapy in patients with advanced gastric cancer].
    Yabusaki H; Nashimoto A; Tanaka O
    Gan To Kagaku Ryoho; 2003 Nov; 30(12):1933-40. PubMed ID: 14650962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I/II trial of combination therapy with S-1 and weekly paclitaxel in patients with unresectable or recurrent gastric cancer.
    Inada S; Tomidokoro T; Fukunari H; Sato T; Hatano T; Nishimura A; Kawauchi Y; Nikkuni K; Shimizu T; Sato T; Yanagi M; Takahashi S; Yoshida H; Sugita M; Hayashi T
    Cancer Chemother Pharmacol; 2009 Jan; 63(2):267-73. PubMed ID: 18379784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [S-1+Low-Dose CDDP].
    Nakata B; Tsuji A; Hirakawa K
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():68-74. PubMed ID: 16897975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I study of the sequential administration of S-1 and cisplatin for metastatic gastric cancer.
    Baba E; Fujishima H; Kusaba H; Esaki T; Ariyama H; Kato K; Tanaka R; Mitsugi K; Shibata Y; Harada M; Nakano S
    Anticancer Res; 2009 May; 29(5):1727-32. PubMed ID: 19443394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I pharmacokinetic study of S-1 plus cisplatin in patients with advanced gastric carcinoma.
    Ajani JA; Faust J; Ikeda K; Yao JC; Anbe H; Carr KL; Houghton M; Urrea P
    J Clin Oncol; 2005 Oct; 23(28):6957-65. PubMed ID: 16145066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I/II study of s-1 plus cisplatin combination chemotherapy in patients with advanced/recurrent head and neck cancer.
    Fujii M; Tomita K; Nishijima W; Tsukuda M; Hasegawa Y; Ishitoya J; Yamane H; Homma A; Tomita T
    Jpn J Clin Oncol; 2010 Mar; 40(3):214-21. PubMed ID: 19934112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [TS-1/CDDP therapy for advanced gastric cancer as neoadjuvant chemotherapy].
    Nakamura M; Maruyama K; Furukawa J; Maruyama N; Tanaka J; Katsumoto Y; Yokouchi H; Nakaguchi K; Sue F; Yoshihara W
    Gan To Kagaku Ryoho; 2002 Oct; 29(10):1823-8. PubMed ID: 12402437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer.
    Koizumi W; Tanabe S; Saigenji K; Ohtsu A; Boku N; Nagashima F; Shirao K; Matsumura Y; Gotoh M
    Br J Cancer; 2003 Dec; 89(12):2207-12. PubMed ID: 14676796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A pilot study of low-dose TS-1 and cisplatin combination chemotherapy for advanced gastric cancer].
    Kamata T; Hayashi Y; Minatoya G; Michiwa Y; Onishi I; Takeda T; Koyasaki N; Kanno M
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1419-22. PubMed ID: 11681250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I study of S-1 administration and a 24-h infusion of cisplatin plus paclitaxel in patients with advanced gastric cancer.
    Iwase H; Shimada M; Tsuzuki T; Okeya M; Kobayashi K; Hibino Y; Watanabe H; Goto H
    Anticancer Res; 2006; 26(2B):1605-9. PubMed ID: 16619579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [S-1 combined with weekly paclitaxel in patients with advanced gastric cancer].
    Gotoh M; Kawabe S; Takiuchi H
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():91-4. PubMed ID: 16897980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.